News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Beijing Med-Pharm Corp. (BJGP.PK) to Market Ferriprox(R) in China; Signs Five Year Exclusive Agreement with Canada's Largest Pharmaceutical Company


10/19/2007 9:39:51 AM

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Beijing Med-Pharm Corporation (NASDAQ:BJGP) (“Beijing Med-Pharm” or the “Company”), today announced that it has signed an exclusive, renewable five year agreement with Apotex Inc., to market and distribute Ferriprox® (Deferiprone) in the People's Republic of China.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES